Testing effectiveness (Phase 2)Not Yet RecruitingNCT06574412
What this trial is testing
Cardenilimab Combined With Lenvatinib in Patients With Perioperative Resectable Clear Cell Renal Cell Carcinoma.
Who this might be right for
Resectable Clear Cell Carcinoma of the Kidney
The First Hospital of Jilin University 30